person

Angelo H.

Country
The Netherlands
Department
Gynaecologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 9 partner sites.

Specializations

Gynecologic Oncology

Research emphasizes targeted therapies for breast cancer. It also investigates prevention of recurrence in vulvar HSIL.

  • adjuvant endocrine therapy combined with CDK4/6 inhibition
  • immune checkpoint blockade in triple‑negative breast cancer
  • non‑avalent HPV vaccination for vulvar HSIL

The goal is to extend survival outcomes for women with hormone‑driven tumors.

Reproductive Medicine

Investigations address challenges of infertility. Additional focus is placed on complications such as placenta previa and the risk of preterm birth.

  • ovarian stimulation protocols for infertility
  • surgical management of placenta previa
  • progesterone therapy to reduce preterm birth

Outcomes focus on fertility preservation and neonatal health.

Cardiovascular Therapeutics

Focus areas include management of atherosclerotic cardiovascular disease, prevention of stroke in atrial fibrillation, and treatment of heart failure.

  • lipid‑lowering strategy for atherosclerotic cardiovascular disease
  • anticoagulation optimization in atrial fibrillation
  • combined therapy for heart failure

Efforts target reduction of major adverse cardiovascular events.

General Oncology

Studies encompass advanced non‑small cell lung cancer, strategies for colorectal carcinoma, and therapies for hematologic malignancies such as diffuse large B‑cell lymphoma, chronic lymphocytic leukemia and multiple myeloma.

  • targeted agents for non‑small cell lung cancer
  • de‑escalated chemotherapy in colorectal carcinoma
  • novel regimens for diffuse large B‑cell lymphoma
  • BTK inhibition in chronic lymphocytic leukemia
  • proteasome inhibition for multiple myeloma

Studies aim to improve response rates across solid and hematologic malignancies.

Neuroimmunology

Evaluation of disease‑modifying strategies for multiple sclerosis and related autoimmune neuro conditions.

  • anti‑CD20 therapy assessment in multiple sclerosis
  • neuro‑immune modulation for relapsing MS

Research seeks to limit disability progression in autoimmune neuro disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.